Form 4: Insider Trades at Prestige Consumer Healthcare

Mekhail Adel, EVP of Marketing & Sales at Prestige Consumer Healthcare Inc., reported a transaction involving company common stock.

Summary

• Mekhail Adel, Executive Vice President of Marketing & Sales for Prestige Consumer Healthcare Inc. (PBH), reported a transaction on May 2, 2026.
• The transaction involved the acquisition of 542 shares of common stock at a price of $55.09 per share.
• Following this transaction, Adel beneficially owns 20,366 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing due to an insider purchase, indicating potential confidence from management, but lacking broader financial or strategic disclosures.

Positives

• Insider purchase of company stock by a key executive, which can signal confidence in the company's future prospects.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly purchases by senior executives, are often closely watched by investors as they can provide insights into management's perception of the company's valuation and future performance within the consumer healthcare sector.

Stakeholder Impact

• Shareholders may view this insider purchase positively, interpreting it as a sign of confidence in the company's value and future performance.

Key Dates

Keywords

Prestige Consumer Healthcare, PBH, Form 4, Insider Trading, Stock Transaction, Executive Purchase